• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans


Adverts help to support the work of this non-profit organisation. To go ad-free join as a Member.


Photo

Aastrom


  • Please log in to reply
150 replies to this topic

#61 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 01 June 2011 - 12:13 PM

Trial results expected from Aastrom Biosciences
BioMedReports - 2 hours ago
about 6 minutes ago Trial results expected from Aastrom Biosciences: Aastrom Biosciences, Inc. (Nasdaq:ASTM) the leading developer ... http://bit.ly/m2v835 about 10 hours ago Aegerion Announces ...

View the full article

#62 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 13 June 2011 - 12:16 PM

Stem Cell Stocks Remain Some of the Most Volatile in the Market
Marketwire - 1 hour ago
NEW YORK, NY--(Marketwire - Jun 13, 2011) - Stem Cell stocks continue to be some of the most volatile in the market. While scientists firmly believe that stem cells are the future of medicine, and ...

View the full article

#63 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 16 June 2011 - 08:40 PM

Aastrom Files At-the-Market Offering and New Shelf Registration Statement
MarketWatch - 22 hours ago
ANN ARBOR, Mich., Jun 16, 2011 (GlobeNewswire via COMTEX) -- Aastrom Biosciences, Inc. /quotes/zigman/116807/quotes/nls/astm ASTM -2.02% , the leading developer of patient-specific, expanded ...

View the full article

sponsored ad

  • Advert

#64 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 21 June 2011 - 08:18 PM

Aastrom Establishes Independent Steering Committee for REVIVE Phase 3 CLI Clinical Program
MarketWatch - 18 hours ago
ANN ARBOR, Mich., Jun 21, 2011 (GlobeNewswire via COMTEX) -- Aastrom Biosciences, Inc. /quotes/zigman/116807/quotes/nls/astm ASTM +2.73% , the leading developer of patient-specific, expanded ...
Aastrom Biosciences (ASTM) Forms Independent Steering Committee for REVIVE Phase 3 CLI Clinical Program - StreetInsider.com
Aastrom Forms Independent Committee For REVIVE Phase 3 CLI Clinical Program - RTT News

View the full article

#65 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 23 June 2011 - 08:18 PM

Journal of Vascular Surgery Publishes Interim Results of RESTORE-CLI Phase 2b Clinical Trial
MarketWatch - 2 hours ago
ANN ARBOR, Mich., Jun 23, 2011 (GlobeNewswire via COMTEX) -- Aastrom Biosciences, Inc. /quotes/zigman/116807/quotes/nls/astm ASTM +3.52% , the leading developer of patient-specific, expanded ...

View the full article

#66 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 24 June 2011 - 03:05 PM

Healthcare Stocks Looking Up, ATRC, ASTM, GTIV, ENZ
The Markets Are Open - 4 hours ago
AtriCure Inc. (ATRC) shares was up 2.55% today, moving to $12.45 per share. Stock volume in AtriCure Inc. was 24,204 shares in the trading session. Aastrom Biosciences, Inc. (ASTM) shares pressed ...
Gains in Healthcare Sector (ENZ) (ACHN) (GTIV) (ASTM) - Tickr Watch

View the full article

#67 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 27 June 2011 - 11:47 AM

The Long And Short Of Aastrom Biosciences
RTT News - 2 hours ago
(RTTNews) - As regenerative medicine company Aastrom Biosciences Inc. (ASTM: News ) continues to make progress with its ongoing clinical trial programs, there are a couple of events coming up in ...

View the full article

#68 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 30 June 2011 - 04:17 PM

Bouncing Back from the Dark Side: ASTM, GIGM, BPAX
Small Cap Network - 2 hours ago
By Dennis Askew Taking a look at Aastrom Biosciences Inc (NASDAQ: ASTM), BioSante Pharmaceuticals Inc (NASDAQ: BPAX), and GigaMedia Ltd (NASDAQ: GIGM) certainly inspires hope. Sometimes it's very ...

View the full article

#69 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 22 July 2011 - 05:38 PM

Climbing Back Up the Hill of Share Value: ASTM, OWW, PSUN
Small Cap Network - 1 hour ago
Getting out of the Red Day by Day and a Few Cents at a Time. By Dennis Askew This grouping of companies, Aastrom Biosciences Inc (NASDAQ: ASTM), Orbitz Worldwide Inc (NYSE: OWW), and Pacific ...

View the full article

#70 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 25 July 2011 - 03:27 PM

Can They Keep the Momentum Going? LRAD, ASTM, CBB
Small Cap Network - 2 hours ago
By Dennis Askew The following three companies, LRAD Corporation (NASDAQ: LRAD), Aastrom Biosciences Inc (NASDAQ: ASTM), and Cincinnati Bell Inc (NYSE: CBB), have all had a good month, spurred on ...

View the full article

#71 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 26 July 2011 - 11:04 AM

Aastrom Announces Agreement From FDA on Special Protocol Assessment for Phase 3 Clinical Trial in No-Option Critical Limb Ischemia Patients
MarketWatch - 7 minutes ago
ANN ARBOR, Mich., Jul 26, 2011 (GlobeNewswire via COMTEX) -- Aastrom Biosciences, Inc. /quotes/zigman/116807/quotes/nls/astm ASTM +1.40% , the leading developer of patient-specific, expanded ...

View the full article

#72 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 26 July 2011 - 04:05 PM

Coronado readies IND for Crohn's treatment; Aastrom reaches agreement on SPA for critical limb ischemia study;
FierceBiotech - 2 hours ago
@JohnCFierce: Under pressure to speed things up, FDA Commissioner Margaret Hamburg is looking to loosen conflict rules for adcomm members. Report | Follow @JohnCFierce @RyanMFierce: Icon's buyout ...

View the full article

#73 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 26 July 2011 - 03:51 PM

Needham & Company Maintains a 'Buy' on Aastrom Biosciences (ASTM); SPA in the Summer Worth the Wait - Phase 3 Stem Cell Ixmyelocel-T Trial
StreetInsider.com - 2 hours ago
Needham analyst says, "This morning, Aastrom announced an agreement with the FDA on the Special Protocol Assessment (SPA) for ... StreetInsider.com provides up-to-the-minute active trading news ...

View the full article

#74 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 09 August 2011 - 04:02 PM

Aastrom Enters Final-Stage Trial With Stem-Cell Therapy for CLI Patients
Xconomy - 2 hours ago
“The FDA encouraged us to pursue this [Special Protocol Assessment] process since there aren'ta lot of new therapies for iscemia,” said Aastrom CEO Tim Mayleben. “The Special Protocol Assessment ...

View the full article

#75 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 12 August 2011 - 12:42 PM

Global Hunter Securities Starts Aastrom Biosciences (ASTM) at Speculative Buy; Ixmyelocel-T a Potentially Significant Driver
StreetInsider.com - 1 minute ago
Global Hunter Securities initiates coverage on Aastrom Biosciences (NASDAQ: ASTM) with a Speculative Buy. PT $6.00. Global analyst says, "ASTM is developing cell-based therapies for use in the ...

View the full article

#76 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 12 August 2011 - 01:51 PM

MultiCell Technology and Aastrom Biosciences Aim to Shatter Stem Cell Myths
PR-USA.net - 2 hours ago
With Americans spending in excess of $300 billion annually on drugs which typically only treat disease symptoms, regenerative therapies are garnering increased support. Scientists argue that stem ...

View the full article

#77 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 11 August 2011 - 08:04 PM

Aastrom Announces Adoption of Shareholder Rights Plan
MarketWatch - 20 hours ago
ANN ARBOR, Mich., Aug 11, 2011 (GlobeNewswire via COMTEX) -- Aastrom Biosciences, Inc. /quotes/zigman/116807/quotes/nls/astm ASTM +6.73% ("Aastrom" or the "Company"), the leading developer of ...
Global Hunter Securities Starts Aastrom Biosciences (ASTM) at Speculative Buy; Ixmyelocel-T a Potentially Significant Driver - StreetInsider.com

View the full article

#78 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 14 August 2011 - 02:02 PM

6 Recently Crushed Stocks With Heavy New Insider Buying
Seeking Alpha - 17 hours ago
A major market correction is creating some new stock bargains that insiders are taking advantage of at several companies. The amount of insider buying has surged in the last few days, and a new ...

View the full article

#79 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 25 August 2011 - 07:08 PM

EPS below consensus: ASTM, KH, HTHT
Rapid News Network - 23 minutes ago
Aastrom Biosciences, Inc. (Public, NASDAQ:ASTM). Last Market Price: 2.47, Change: +0.03, % Change: (1.23%). Shares trade in the range of 2.37 – 2.51 dollars. It has a market capitalization of 95 ...

View the full article

#80 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 14 September 2011 - 01:02 PM

Aastrom to Present 12-Month Data From the IMPACT-DCM Phase 2 Clinical Trial for Ixmyelocel-T in Treatment of Dilated Cardiomyopathy
MarketWatch - 3 hours ago
ANN ARBOR, Mich., Sep 14, 2011 (GlobeNewswire via COMTEX) -- Aastrom Biosciences, Inc. /quotes/zigman/116807/quotes/nls/astm ASTM +1.24% , a leading developer of patient-specific, expanded ...
Aastrom Biosciences (ASTM) to Present Ixmyelocel-T Data - StreetInsider.com

View the full article

#81 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 15 December 2010 - 09:01 PM


View the full article

#82 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 19 September 2011 - 01:15 PM

Aastrom Announces Positive 12-Month Safety and Efficacy Data From IMPACT-DCM Phase 2 Clinical Trial for Ixmyelocel-T in Treatment of Dilated Cardiomyopathy
TradersHuddle.com - 2 hours ago
ANN ARBOR, Mich., Sept. 19, 2011 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific, expanded multicellular therapies for the treatment of ...

View the full article

#83 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 23 September 2011 - 01:05 PM

Aastrom to Present at the Sixth Annual JMP Securities Healthcare Conference
MarketWatch - 1 hour ago
ANN ARBOR, Mich., Sep 23, 2011 (GlobeNewswire via COMTEX) -- Aastrom Biosciences, Inc. /quotes/zigman/116807/quotes/nls/astm ASTM 0.00% , the leading developer of patient-specific, expanded ...

View the full article

#84 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 03 October 2011 - 01:03 PM

Aastrom Granted European Composition-of-Matter Patent for Ixmyelocel-T
MarketWatch - 2 hours ago
ANN ARBOR, Mich., Oct 3, 2011 (GlobeNewswire via COMTEX) -- Aastrom Biosciences, Inc. /quotes/zigman/116807/quotes/nls/astm ASTM -3.12% , the leading developer of patient-specific, expanded ...
Aastrom Bio (ASTM) Receives Patent Protection for Ixmyelocel-T in EU - StreetInsider.com

View the full article

#85 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 04 October 2011 - 05:18 PM

Investors look to Lighten Up on Shares of Aastrom Biosciences, Shares Down 2.3% (ASTM)
Financial News Network Online - 2 hours ago
Aastrom Biosciences (NASDAQ:ASTM) is one of today's worst performing low-priced stocks, down 2.3% to $2.11 on 0.9x average daily volume.Thus far today, Aastrom Biosciences has traded 208,000 ...

View the full article

#86 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 13 October 2011 - 08:06 PM

Aastrom Appoints Brian Gibson as Vice President, Finance
MarketWatch - 21 hours ago
ANN ARBOR, Mich., Oct 13, 2011 (GlobeNewswire via COMTEX) -- Aastrom Biosciences, Inc. /quotes/zigman/116807/quotes/nls/astm ASTM 0.00% , the leading developer of patient-specific, expanded ...
Aastrom Biosciences (ASTM) Names Brian Gibson as Chief Accounting Officer and Treasurer - StreetInsider.com
AASTROM BIOSCIENCES, INC.: Aastrom Appoints Brian Gibson as Vice President.. - 4-traders

View the full article

#87 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 24 October 2011 - 01:56 PM

Leg-saving cell therapy
Stockopedia - 1 hour ago
Oct 24th 2011 - Edison Investment Research today published a report on Aastrom Biosciences entitled "Leg-saving Cell Therapy". In summary, the report says: Aastrom has developed a patient-specific ...

View the full article

#88 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 24 October 2011 - 12:33 PM

Werner (WERN) (AGPPY) (ASTM) (CMRE) (DM) (DSX) Get New Coverage
Everything Gold - 3 hours ago
Werner Enterprises, Inc. (NASDAQ: WERN), Anglo Platinum Limited (OTC: AGPPY), Aastrom Biosciences Inc. (NASDAQ: ASTM), Comstock Resources (NASDAQ: CMRE), The Dolan Company (NYSE: DM) and Diana ...

View the full article

#89 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 24 October 2011 - 01:56 PM

Edison Expands Cell Therapy Sector Presence with Launch of Research Coverage on Aastrom
MarketWatch - 5 hours ago
LONDON, Oct 24, 2011 (BUSINESS WIRE) -- Edison Investment Research, a UK-based independent equity research firm, announces the initiation of research coverage on Aastrom Biosciences, Inc /quotes ...
Leg-saving cell therapy - Stockopedia

View the full article

#90 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 25 October 2011 - 08:55 AM

6 Biotech Stocks Undervalued By Their Levered Free Cash Flows
Seeking Alpha - 16 minutes ago
Contrary to what you may expect, many publicly traded biotech firms do not yet produce significant cash flows. This is because many biotechs are developing products but do not yet have a drug on ...

View the full article




0 user(s) are reading this topic

0 members, 0 guests, 0 anonymous users